openPR Logo
Press release

Albumin Market Business Growth Statistics and Key Players Insights: Grifols S.A., Octapharma AG, China Biologic Products Inc., Shire Plc, Ventria Bioscience, CSL Limited, Albumedix Ltd., Merck KGaA

11-01-2018 11:27 AM CET | Health & Medicine

Press release from: Allied Market Research

Albumin Market

Albumin Market

Global Albumin Market is projected to reach $10,305 million in 2023, registering a CAGR of 9.6% from 2017 to 2023.Albumin is globular protein found in liquid component of blood called plasma. It is most abundant protein in plasma constituting around 50% of the total protein in the blood. It plays a vital role in maintaining proper oncotic pressure of blood and transporting hormones, fatty acids, and other compounds throughout the body. It is derived from blood plasma on fractionation, and is widely used to clinically to treat variety of diseases. Different types of albumin are used clinically. These include human serum albumin, bovine serum albumin, and recombinant albumin.

The factors that drive the growth of the albumin market include increase in prevalence of life-threatening diseases and conditions namely surgical procedures, liver diseases, trauma and burns cases, and others. Moreover, rise in awareness about recombinant albumin products, upsurge in demand for albumin products, and growth in non-therapeutic application of albumin also fuel the growth of the market.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2583?utm_source=sy-Openpr


The key players of this market include
• Grifols S.A.
• Octapharma AG
• China Biologic Products Inc.
• Shire Plc
• Ventria Bioscience
• CSL Limited
• Albumedix Ltd.
• Merck KGaA
• Thermo Fisher Scientific
• Baxter International Inc.

Other players (these players are not profiled in the report and the same can be included on request) in the value chain include Biotest AG, Medxbio Pte Ltd., Mitsubishi Tanabe Pharma Corporation, Kedrion S.p.A, HiMedia Leading BioSciences Company, and Celgene Corporation.

However, stringent governmental regulations and reforms, and risk of side effects associated after using albumin products impede the market growth. Conversely, the development of cost-effective therapeutic along with large production of albumin and presence of untapped market in emerging economies are expected to provide lucrative growth opportunities for the market.

The human serum albumin segment accounted for the largest share in 2016, owing to high usage as blood volumizer and applicability for treating variety of diseases and improved human serum albumin production due to the emergence of advanced technologies. However, the recombinant albumin segment is expected to grow at the high CAGR from 2017 to 2023.

The utilization rate of albumin for therapeutics is high owing to rise in prevalence of trauma and cases of burns as well as increase in the number of surgical procedures. However, drug formulation and vaccines segment is expected to grow at a high CAGR during the forecast period.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/2583?utm_source=sy-Openpr


Key Findings of the Albumin Market:

• The bovine serum albumin segment accounted for nearly one-eighth share of the global albumin market in 2016.
• The recombinant albumin segment is expected to grow at highest CAGR from 2017 to 2023.
• The component of media segment accounted for around one-fifth share of the global market in 2016.
• Europe accounted for around one-third share of the global market in 2016.
• LAMEA is expected to provide lucrative market growth opportunities from 2017 to 2023.

North America was the leading revenue contributor to the global albumin market in 2016, and is expected to dominate the market during the forecast period. This is attributed to the early approval of albumin products and high adoption of recombinant albumin in this region. However, Asia-Pacific is expected to grow at the highest CAGR during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward albumin products.

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/human-albumin-market.html?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Albumin Market Business Growth Statistics and Key Players Insights: Grifols S.A., Octapharma AG, China Biologic Products Inc., Shire Plc, Ventria Bioscience, CSL Limited, Albumedix Ltd., Merck KGaA here

News-ID: 1345211 • Views:

More Releases from Allied Market Research

Home Exercise Bike Market is expected to witness robust Compound Annual Growth Rate (CAGR) progress of 8.7% from 2021 to 2027.
Home Exercise Bike Market is expected to witness robust Compound Annual Growth R …
According to a new report published by Allied Market Research, titled, "Home Exercise Bike Market by Type, and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," The global home exercise bike market size was valued at $1,213.5 million in 2019, and is projected to reach $2,335.2 million by 2027, registering a CAGR of 8.7% from 2021 to 2027. The recumbent segment is expected to retain its dominant position, in terms
Rapidly expanding entertainment products industry is set to drive the growth of the $103.8 billion Toys market ; Ravensburger AG, Tomy Company, Ltd, Vtech Holdings, and Thames & Kosmos.
Rapidly expanding entertainment products industry is set to drive the growth of …
According to a new report published by Allied Market Research, titled, "Toys Market by Product Type, Age Group and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," the toys market size was $92.2 billion in 2019, and is projected reach $103.8 billion by 2027, registering a CAGR of 2.5% from 2021 to 2027. The increase in number of games bars, cafes and family entertainment centers worldwide is boosting the demand for
Global Home Beer Brewing Machine Market is expected to reach $25.4 million by the year 2030, as projected by Allied Market Research.
Global Home Beer Brewing Machine Market is expected to reach $25.4 million by th …
According to a new report published by Allied Market Research, titled, "home beer brewing machine market by product type, mechanism, and distribution channel: global opportunity analysis and industry forecast, 2021-2030," The global home beer brewing machine market size was valued at $19.1 million in 2020, and is projected to reach $25.4 million by 2030, registering a CAGR of 3.0% from 2021 to 2030. Request a report sample to gain comprehensive insights
Hospitality Robots Market is forecasted to grow at a Compound Annual Growth Rate (CAGR) of 25.5% through the year 2030, according to Allied Market Research.
Hospitality Robots Market is forecasted to grow at a Compound Annual Growth Rate …
According to a new report published by Allied Market Research, titled, "Hospitality Robots Market by Type, End User, Sales Channel and Region: Global Opportunity Analysis and Industry Forecast, 2021-2030," The global hospitality robots market size is expected to reach $3,083 million by 2030 at a CAGR of 25.5% from 2021 to 2030. Hospitality Robots Market by Type (Front Desk Robots, Delivery Robots, Cleaning Robots and Others) and end user (Hotels,

All 5 Releases


More Releases for Albumin

Albumin Market: Therapeutic Action of Albumin on Liver Function and Blood Circul …
The use of albumin to treat multiple types of deficiencies, including those related to blood volume, is giving an impetus to market growth. It is a high-utility, human-derived protein that has applications across a spectrum of medical operations. Conditions such as hypoalbuminemia, caused by severe injuries, and rapid protein loss due to third-degree burns can be effectively managed through intravenous administration of albumin. Furthermore, albumin administration is the last resort
Albumin Market Geographical Segmentation, Competitive Analysis, Latest Rising Tr …
This intelligence report provides a comprehensive analysis of the Albumin Market. This includes investigating past progress, ongoing market scenarios, and future prospects. Accurate data on the products, strategies and market share of leading companies in this particular market are mentioned. This report provides a 360-degree overview of the global market's competitive landscape. The report further predicts the size and valuation of the global market during the forecast period. Albumin is a
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Albumin Market: Increase in Usage of Albumin as Multifunctional Excipient to Boo …
Transparency Market Research (TMR) has published a new report titled, “Albumin (as Excipient) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global albumin (as excipient) market was valued at US$ 750 Mn in 2017 and is anticipated to reach US$ 1200 Mn by 2026 at a CAGR of over 5.0% from 2018 to 2026. Grant of regulatory approvals coupled with
Albumin Market: Substantial Use of Human Serum Albumin as Pharmaceutical Excipie …
Albumin Market: Snapshot Prominent companies operating in the global albumin market are focusing on product and service extensions to grow their shares. This is serving to stoke competition in the market. In the near future, the competition is slated to intensify further on account of the savvy players striking partnerships or acquiring distributors to augment sales and expand businesses, globally. At the forefront of driving growth in the global albumin market is
Albumin Market: Substantial Use of Human Serum Albumin as Pharmaceutical Excipie …
Albumin Market: Snapshot Prominent companies operating in the global albumin market are focusing on product and service extensions to grow their shares. This is serving to stoke competition in the market. In the near future, the competition is slated to intensify further on account of the savvy players striking partnerships or acquiring distributors to augment sales and expand businesses, globally. At the forefront of driving growth in the global albumin market is